Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

1(33%)

Results Posted

0%(0 trials)

Terminated

1(33%)

Phase Distribution

Ph not_applicable

33%

Ph phase_3

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 3Large-scale testing

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(1)

Detailed Status

Completed1

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (50.0%)

N/A1 (50.0%)

Trials by Status

completed133%

recruiting133%

terminated133%

Recent Activity

1 active trials

Showing 3 of 3

recruiting

Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance

NCT06075485

completednot_applicable

Modified Atkins Diet Plus KetoCal for Adult Epilepsy

NCT01834482

terminatedphase_3

Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)

NCT01016522

Clinical Trials (3)

Showing 3 of 3 trials

NCT06075485

Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance

Recruiting

NCT01834482Not Applicable

Modified Atkins Diet Plus KetoCal for Adult Epilepsy

Completed

NCT01016522Phase 3

Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)

Terminated

All 3 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 3